The dystrophin glycoprotein complex is a specialized complex of cardiac and skeletal muscle. The function of the dystrophin glycoprotein complex is not fully understood, but it appears to stabilize the plasma membrane of skeletal and cardiac muscle and serve in a mechanosignaling capacity. Defects in the dystrophin glycoprotein complex lead to skeletal muscle dystrophy and cardiomyopathy in both human patients and mouse models. We previously engineered mouse models lacking gamma-sarcoglycan or delta-sarcoglycan and found that these mice effectively model the human disorder. In mice, as in humans with dystrophin-glycoprotein complex gene defects, there is variability in the phenotypic outcome. We hypothesize that aspects of this phenotypic variability is under genetic control. We now propose to identify new genes and to test existing genes for their ability to modulate the phenotype from sarcoglycan gene mutations. We now show that the genetic background influences two different quantitative features of muscular dystrophy. The degree of fibrosis and the degree of membrane permeability both significantly vary in gamma sarcoglycan null mice related to the specific genetic background. We propose to map these quantitative traits to determine the genetic modifier loci that affect the phenotypic outcome in muscular dystrophy. Genetic modifier genes are useful since they may aid in counseling subjects with muscular dystrophy as well as lead to new avenues of therapy. We will study to additional genetic backgrounds for their ability to suppress the muscular dystrophy and cardiomyopathy phenotypes in gamma sarcoglycan null mice. We show now that defects in the major integrin complex of skeletal muscle lead to a profound muscular dystrophy phenotype with enhanced skeletal muscle degeneration and early lethality. Therefore, we will investigate the cellular and molecular effects of integrin as a modifier of the muscular dystrophy phenotype. Lastly, endothelial nitric oxide synthase will be studied as a modifier of the cardiomyopathic features of limb girdle muscular dystrophy using genetic and pharmacologic approaches. These findings will improve our understanding of the cellular defects in muscular dystrophy and cardiomyopathy and may help devise new strategies for therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061322-08
Application #
7070036
Study Section
Skeletal Muscle and Exercise Physiology Study Section (SMEP)
Program Officer
Massicot-Fisher, Judith
Project Start
1999-07-05
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
8
Fiscal Year
2006
Total Cost
$334,500
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Fallon, Justin R; McNally, Elizabeth M (2018) Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics. Matrix Biol 68-69:616-627
Ohiri, Joyce C; McNally, Elizabeth M (2018) Gene Editing and Gene-Based Therapeutics for Cardiomyopathies. Heart Fail Clin 14:179-188
Wyatt, Eugene J; Demonbreun, Alexis R; Kim, Ellis Y et al. (2018) Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight 3:
McNally, Elizabeth M; Wyatt, Eugene J (2017) Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic. Circulation 136:979-981
McNally, Elizabeth M; Mestroni, Luisa (2017) Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res 121:731-748
Quattrocelli, Mattia; Barefield, David Y; Warner, James L et al. (2017) Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest 127:2418-2432
Demonbreun, Alexis R; McNally, Elizabeth M (2017) Muscle cell communication in development and repair. Curr Opin Pharmacol 34:7-14
McNally, Elizabeth M (2017) Gene Editing for the Heart: Correcting Dystrophin Mutations. Circ Res 121:896-898
Quattrocelli, Mattia; Salamone, Isabella M; Page, Patrick G et al. (2017) Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy. Am J Pathol 187:2520-2535
Giacomazzi, Giorgia; Holvoet, Bryan; Trenson, Sander et al. (2017) MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors. Nat Commun 8:1249

Showing the most recent 10 out of 72 publications